The past week was an eventful one for Tesla Inc. (NASDAQ:TSLA) and CEO Elon Musk as shifting political tides cast doubt over the billionaire’s AI goals, while Tesla also looks set to wind down the Cybertruck’s production next year. Let’s take a look at the major headlines this week. Cybertruck Production Will Wind Down Musk, […]
Badar Shaikh | November 8, 2026
Editor’s Note: This article was updated with additional content. The U.S. economy added 165,000 jobs in October, well above the 65,000 economists had expected, the Bureau of Labor Statistics said Friday. Private payrolls rose by 159,000, far above the 64,000 forecast, while government payrolls added 6,000 after shedding 18,000 in September. The unemployment rate fell […]
Piero Cingari | November 6, 2026
On CNBC’s “Mad Money Lightning Round,” Jim Cramer recommended buying FedEx Freight Holding Company, Inc. (NYSE:FDXF), noting, “It’s had a very nice move off the bottom.” Supporting his choice, FedEx Freight reported better-than-expected third-quarter financial results on Oct. 29. When asked about Replimune Group (NASDAQ:REPL), he said, “It’s all spec. It’s all experimental, and so […]
Avi Kapoor | November 4, 2026
Tastytrade founder Tom Sosnoff expects the pullback in the market’s most crowded chip stocks to continue, telling CNBC Monday morning that the rally’s biggest winners have yet to fall anywhere close to oversold levels. The big names at “the top of the funnel”—pointing to Nvidia Corp. (NASDAQ:NVDA), Advanced Micro Devices Inc. (NASDAQ:AMD) and Micron Technology […]
Erica Kollmann | November 2, 2026
Gilead Sciences Inc. (NASDAQ:GILD) stock rose Friday after the biopharmaceutical company reported better-than-expected third-quarter earnings and revenue and raised its full-year sales forecast, driven by strong demand for its HIV treatments. The company also warned of a $1.5 billion revenue headwind in 2028 from Medicare pricing changes affecting its blockbuster HIV drug Biktarvy. Earnings Snapshot […]
Vandana Singh | October 30, 2026
June 10, 2024